英国开始在火鸡中进行为期24周的禽流感疫苗试验,以对抗致命的HPAI,每年耗资1.74亿英镑。 The UK starts a 24-week trial of a bird flu vaccine in turkeys to combat deadly HPAI, which costs £174 million yearly.

联合王国已开始对火鸡禽流感疫苗进行为期24周的试验,目的是评估其对抗高致病性禽流感(HPAI)的效力。 禽流感造成严重的家禽损失,每年耗资达1.74亿英镑。 The UK has begun a 24-week trial of a bird flu vaccine in turkeys, aiming to assess its effectiveness against highly pathogenic avian influenza (HPAI), which has caused severe losses in poultry and cost up to £174 million annually. 审判由DEFRA领导,并由兽医药品局批准,重点是火鸡,因为火鸡高度脆弱。 The trial, led by DEFRA and approved by the Veterinary Medicines Directorate, focuses on turkeys due to their high vulnerability. 虽然在联合王国,例行的家禽疫苗接种在贸易和检测关切方面仍然受到限制,但这项研究力求评价现实世界的保护、监测一体化和对出口的潜在影响。 While routine poultry vaccination remains restricted in the UK over trade and detection concerns, the study seeks to evaluate real-world protection, surveillance integration, and potential impacts on exports. 荷兰、意大利和美国也在进行类似的试验,这反映出全球对疫苗作为管理HPAI的工具的兴趣日益浓厚,尽管生物安保仍是主要防御手段。 Similar trials are underway in the Netherlands, Italy, and the US, reflecting growing global interest in vaccines as a tool to manage HPAI, though biosecurity remains the primary defense.